INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
EXPAND
INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
EXPAND
INOmax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Please see Full Prescribing Information.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.
You are now leaving INOmax.com and entering another Mallinckrodt-hosted website.